Iradimed IRMD
NASDAQ IRMD
$87.10 -0.30 (-0.34%)
At close: Aug 20, 2026 · 2:16 PM UTC

Iradimed (IRMD) Notes Payables (2013)

Iradimed (IRMD) posted quarterly Notes Payables of $6333.0 for Q4 2013.

Iradimed (IRMD) Notes Payables (2013) Analysis & Trends

Iradimed has reported Notes Payables for 1 years, with the latest figure at $6333.0 in Q4 2013.

  • Notes Payables for Q4 2013 came in at $6333.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2013 was $6333.0 (changed N/A YoY), and the FY2013 annual result was $6333.0, changed N/A from the prior year.
  • Notes Payables steadied at $6333.0 in Q4 2013.
  • Over five years, Notes Payables peaked at $6333.0 in Q4 2013 and troughed at $6333.0 in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.61 Bn 194.01 Bn 7.27 Bn
2 Stryker 127.81 Bn 124.34 Bn 4.50 Bn
3 Medtronic 119.04 Bn 109.82 Bn 6.41 Bn
4 Boston Scientific 73.68 Bn 73.14 Bn 3.85 Bn
5 Edwards Lifesciences 51.96 Bn 47.71 Bn 1.35 Bn
6 Dexcom 34.36 Bn 32.41 Bn 830.00 Mn
7 GE HealthCare Technologies 33.83 Bn 31.72 Bn 2.18 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn
9 Steris 23.06 Bn 22.58 Bn 684.20 Mn
10 Iradimed 1.11 Bn 1.05 Bn 15.16 Mn

Historic Data

Download Data
DateValue
Dec 31, 2013 6,333.00